Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page, indicating a minor metadata update. There are no visible changes to study details or page content.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded related topics 'Ovarian cancer' and 'MedlinePlus Genetics' to the page. Removed a government funding/operating status notice.SummaryDifference0.5%

- Check15 days agoChange DetectedOvarian cancer and related MedlinePlus Genetics topics were removed from the MedlinePlus related topics section.SummaryDifference0.1%

- Check30 days agoChange DetectedLast update timestamp for the study record was refreshed; core study content such as eligibility, treatment arms, and locations remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check44 days agoChange DetectedAdded new MedlinePlus Genetics topic: Ovarian cancer; no deletions.SummaryDifference0.2%

- Check52 days agoChange DetectedUpdated government operating-status notice and timeline with new future dates and a new revision tag; removed some past dates and related genetics topic.SummaryDifference4%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.